CollPlant

Products and Technologies for Regenerative and Aesthetic Medicine

Startup

CollPlant is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2004. Products and Technologies for Regenerative and Aesthetic Medicine. The company has raised a total of $89.05M across 14 funding rounds, currently at the Mature stage. CollPlant was founded by Oded Shoseyov. Key investors include Undisclosed Investor(s), Meitav Dash, Alpha Capital, among 7 total investors. The company has 51-200 employees. Core technologies: Biologicals, Genes, Machinery & Robotics, 3D Printing & Additive Manufacturing.

With $89.05M in total funding, CollPlant is a Mature-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released.

$89.05M
Raised
14
Rounds
7
Investors
4
Team
2004
Founded
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiologicalsGenesMachinery & Robotics3D Printing & Additive Manufacturing
At a Glance
Investors

7 investors total

Founders
In the News

138 articles covered by sources including finance.yahoo.com, www.prnewswire.com, techtime.co.il, www.businesswire.com, www.globes.co.il.

finance.yahoo.com · Oct 27, 2025
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
Read article ↗
Frequently Asked Questions
What does CollPlant do?

CollPlant is a regenerative and aesthetic medicine company developing technologies and products for tissue regeneration and organ manufacturing. Its revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, CollPlant is developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics.

How much funding has CollPlant raised?

CollPlant has raised $89.05M in total funding across 14 rounds. The company is currently at the Mature stage. Key investors include Undisclosed Investor(s), Meitav Dash, Alpha Capital.

Who founded CollPlant?

CollPlant was founded in 2004 by Oded Shoseyov (Founder, Chief Scientist).

What sector is CollPlant in?

CollPlant operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Genes, Machinery & Robotics, 3D Printing & Additive Manufacturing. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Life Sciences, Pharmaceuticals.

Where is CollPlant located?

CollPlant is based in Prof. Hillel ve-Khanan Oppenheimer St 4, Rehovot, Israel, Center District.

View Full Profile Classic View Website ↗